Table 7 Changes in biochemical parameters after 8 weeks of supplementation compared to baseline
Parameter (Units) | Placebo (n = 20) | LI10903F (n = 20) | P value |
|---|---|---|---|
Liver Function | |||
SGOT (U/L) | −1.50 ± 3.63 | −2.55 ± 6.36 | 0.397 |
SGPT (U/L) | −7.65 ± 2.65 | −11.70 ± 4.65 | 0.839 |
Cardiac Function | |||
Systolic BP (mm Hg) | −2.40 ± 3.00 | −12.53 ± 3.92 | 0.105 |
Diastolic BP (mm Hg) | −0.70 ± 2.07 | −5.05 ± 2.89 | 0.975 |
Pulse rate (beats/min) | 0.80 ± 1.48 | −0.11 ± 1.06 | 0.786 |
Metabolic panel | |||
Cholesterol (mg/dL) | 12.20 ± 7.47 | −1.2 ± 6.83 | 0.119 |
Triglycerides (mg/dL) | −8.76 ± 17.32 | −26.50 ± 30.27 | 0.041* |
LDL (mg/dL) | −23.43 ± 7.08 | −11.64 ± 13.37 | 0.155 |
HDL (mg/dL) | −3.04 ± 1.23 | 1.33 ± 4.44 | 0.873 |
Fasting Glucose (mg/dL) | −6.20 ± 10.68 | −16.15 ± 7.35 | 0.445 |